Respiratory Research · 2008 · 16 citations · 45 references
Life SciencesImmunologyPharmacologyAllergyHypersensitivityInflammationAllergen ExposureAllergic ConditionsAnaphylaxisIge-mediated AllergyInflammatory Cell ResponsesRespiratory AllergyAlbuterol TherapyAllergic Airway InflammationImmune Cell ActivationInflammatory Cytokine SecretionMurine ModelsNf-kappa B-dependent TranscriptionNf-κb SignalingT Cell-mediated Lung Inflammation
Racemic albuterol is an equimolar mixture of two isomers, (R) and (S). Whether (R) and (S) isomers and the combination of both exert different effects in immune activation is not well defined. We analyzed the effects of (R+S)-albuterol, (R)-albuterol and (S)-albuterol in a murine model of allergic pulmonary inflammation and in activated T cells. Mice (C57BL/6) sensitized and aerosol challenged with the allergen ovalbumin (OVA) or phosphate buffered saline (PBS) were treated with (R)-albuterol, (S)-albuterol or (R+S)-albuterol. Following administration of (R)-albuterol, allergen induced bronchoalveolar lavage eosinophils and IgE showed a decrease, albeit not significantly by ANOVA. As T cells are important in allergic inflammation, we asked whether (R+S), (R) or (S)-albuterol might differ in effects on T cells and on the activity of the inflammatory transcription factor NF-kappaB. In activated T cells, (R)-albuterol administration decreased levels of inflammatory cytokines and NF-kappaB activity. These studies suggest that (R)-albuterol decreases cytokine secretion and NF-kappaB activity in T cells.
45
Andrew Bentley, Sun Ying, A KAY et al. · Journal of Allergy and Clinical Immunology · 1993 · 585 citations · Full text